Roots Analysis has done a detailed study on Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers.” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html
Key Market Insights
For more information, please visit https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Cancer Statistics and Burden of the Disease
3.3. Importance of Early Cancer Detection
3.4. Cancer Screening and Diagnosis
3.5. Conventional Invasive Cancer Diagnostic Tests
3.5.1. Biopsy
3.5.1.1. Fine Needle Aspiration Biopsy
3.5.1.2. Core Needle Biopsy
3.5.1.3. Vacuum-Assisted Biopsy
3.5.1.4. Image-Guided Biopsy
Press Release: Variation 2 (Format 3)
3.5.1.5. Sentinel Node Biopsy
3.5.1.6. Surgical Biopsy
3.5.1.7. Endoscopic Biopsy
3.5.1.8. Bone Marrow Biopsy
3.5.2. Endoscopy
3.6. Need for Non-Invasive Approaches
3.7. Liquid Biopsy: Diagnosing Circulating Biomarkers
3.7.1. Circulating Tumor Cells
3.7.2. Circulating Tumor DNA
3.7.3. Exosomes
3.8. Costs and Benefits Associated with Liquid Biopsy and Non-Invasive Tests
3.9. Emerging Trends in Intellectual Property Related to Non-Invasive Cancer Diagnostics
3.10. Challenges Associated with Non-Invasive Cancer Diagnostics
3.11. Future Perspectives
4. NON-INVASIVE CANCER SCREENING AND DIAGNOSIS
4.1. Chapter Overview
4.2. Diagnostic Imaging
4.2.1. Magnetic Resonance Imaging (MRI)
4.2.2. Mammography
4.2.3. Bone Scan
4.2.4. Computerized Tomography (CT) Scan
4.2.5. Integrated Positron Emission Tomography (PET)-CT Scan
4.2.6. Ultrasound
4.2.7. X-ray Radiography (Barium Enema)
4.3. Screening Assays
4.3.1. Circulating Tumor Marker Test
4.3.2. Digital Rectal Exam (DRE)
4.3.3. Fecal Occult Blood Test (FOBT)
4.3.4. Multigated Acquisition (MUGA) Scan
4.3.5. Papanicolaou Test and Human Papilloma Virus Test
4.4. Advanced Non-Invasive Approaches
4.4.1. Cytogenetic / Gene Expression Studies
4.4.2. Molecular Signature-based Non-Invasive Methods
4.4.3. Saliva-based Oral Cancer Diagnostics
4.4.4. Vital Staining
4.4.5. Optical Biopsy
4.4.6. Other Diagnostic Techniques
5. MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Liquid Biopsy Products: List of Developers
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size and Geographical Location
5.2.3. Leading Players
5.2.4. Analysis by Geography
5.3. Liquid Biopsy Products: List of Available / Under Development Products
5.3.1. Analysis by Status of Development
5.3.2. Analysis by Type of Product
5.3.3. Analysis by Application Area
Press Release: Variation 2 (Format 3)
5.3.4. Analysis by Target Cancer Indication
5.3.5. Analysis by Type of Tumor Marker
5.3.6. Analysis by End User
5.3.7. Analysis by Turnaround Time
5.4. Liquid Biopsy Products: List of Other Products, Kits an
- Everyone wants to pass the exam in first try. Visit CertsAdvice website for an easy preparation of your exam
- Marketing automation is one of the great processes that help businesses not only to automate their repetitive marketing tasks.
- 100% real and updated exam questions with answers for all famous certifications. Pass in first attempt .Error Free Products with 24/7 Customer Support.Special discount offer for all customer
- 75,185 miles per hour to 11,184 miles per hour.The Hope Probes team considered this phase of the spacecrafts arrival at Mars